Pro-Dex, Inc. (PDEX) Surpasses Q2 Earnings and Revenue Estimates

Financial Performance - Pro-Dex, Inc. reported quarterly earnings of $0.61 per share, exceeding the Zacks Consensus Estimate of $0.38 per share, and showing a significant increase from $0.14 per share a year ago, representing an earnings surprise of 60.53% [1] - The company posted revenues of $16.79 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 21.69%, compared to $12.59 million in the same quarter last year [2] - Over the last four quarters, Pro-Dex has surpassed consensus EPS estimates two times and topped consensus revenue estimates twice [2] Stock Performance - Pro-Dex shares have declined approximately 7.5% since the beginning of the year, while the S&P 500 has gained 2.7% [3] - The current Zacks Rank for Pro-Dex is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.43 on revenues of $15.7 million, and for the current fiscal year, it is $2 on revenues of $61 million [7] - The estimate revisions trend for Pro-Dex is mixed, and changes in earnings expectations may occur following the recent earnings report [6] Industry Context - Pro-Dex operates within the Medical - Dental Supplies industry, which is currently ranked in the bottom 40% of over 250 Zacks industries [8] - The performance of Pro-Dex's stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]